We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Puma Biotechnology
PBYI
$454M
| $112K | 0.01% |
37,700
+12,900
| +52% | +$40.4K |
|
1027
Target Hospitality
TH
$1.65B
| $111K | 0.01% |
+16,918
| New | +$136K |
|
1028
Amneal Pharmaceuticals
AMRX
$5.52B
| $110K | 0.01% |
13,093
+2,349
| +22% | +$19.6K |
|
1029
Enovix
ENVX
$1.03B
| $110K | 0.01% |
+17,081
| New | +$152K |
|
1030
Uranium Energy
UEC
$5.68B
| $109K | 0.01% |
22,857
-32,835
| -59% | -$206K |
|
1031
Sunrun
RUN
$2.43B
| $108K | 0.01% |
+18,504
| New | +$152K |
|
|
OLO
1032
DELISTED
Olo Inc
OLO
| $106K | 0.01% |
17,538
-2,113
| -11% | -$14.8K |
|
1033
Valley National Bancorp
VLY
$8.13B
| $106K | 0.01% |
+11,915
| New | +$113K |
|
1034
Quad
QUAD
$507M
| $105K | 0.01% |
19,284
+2,600
| +16% | +$16.5K |
|
1035
Codere Online
CDRO
$405M
| $104K | 0.01% |
14,292
+1,195
| +9% | +$8.43K |
|
1036
Harmonic Inc
HLIT
$1.26B
| $103K | 0.01% |
10,689
-629,537
| -98% | -$6.94M |
|
1037
TETRA Technologies
TTI
$1.29B
| $103K | 0.01% |
30,507
-2,233
| -7% | -$8.9K |
|
|
GLDD
1038
DELISTED
Great Lakes Dredge & Dock
GLDD
| $101K | 0.01% |
+11,591
| New | +$116K |
|
1039
Green Plains
GPRE
$1.1B
| $99.8K | 0.01% |
20,576
-8,759
| -30% | -$62.7K |
|
1040
NexGen Energy
NXE
$7.07B
| $99.4K | 0.01% |
22,139
-8,440
| -28% | -$49.9K |
|
|
TEAD
1041
Teads Holding Co
TEAD
$66.4M
| $99.3K | 0.01% |
26,620
+6,600
| +33% | +$37.3K |
|
1042
Algonquin Power & Utilities
AQN
$4.46B
| $98.5K | 0.01% |
19,171
+6,350
| +50% | +$30K |
|
1043
Ranpak Holdings
PACK
$459M
| $98K | 0.01% |
+18,074
| New | +$119K |
|
|
ITOS
1044
DELISTED
iTeos Therapeutics
ITOS
| $97.6K | 0.01% |
16,344
+5,736
| +54% | +$42.1K |
|
1045
Ivanhoe Electric
IE
$1.78B
| $96.3K | 0.01% |
+16,582
| New | +$105K |
|
1046
Oil States International
OIS
$530M
| $96.3K | 0.01% |
18,700
-2,300
| -11% | -$12.1K |
|
1047
Stoneridge
SRI
$200M
| $95.9K | 0.01% |
+20,900
| New | +$106K |
|
1048
Tredegar Corp
TG
$282M
| $95.5K | 0.01% |
12,400
-400
| -3% | -$3.08K |
|
1049
KRONOS Worldwide
KRO
$1.01B
| $95.3K | 0.01% |
12,743
+437
| +4% | +$3.85K |
|
1050
Bitdeer Technologies
BTDR
$2.11B
| $91.6K | 0.01% |
10,378
-35,276
| -77% | -$527K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
MCM
CC
MB
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.